208 related articles for article (PubMed ID: 33161303)
1. A retrospective, observational study of perampanel in refractory and super-refractory status epilepticus.
Alsherbini K; Abhi Pandhi F; Goyanes J; Deep A; Jones GM
J Neurol Sci; 2020 Dec; 419():117214. PubMed ID: 33161303
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review.
Lim SN; Wu T; Tseng WJ; Chiang HI; Cheng MY; Lin WR; Lin CN
J Neurol; 2021 Oct; 268(10):3744-3757. PubMed ID: 33754209
[TBL] [Abstract][Full Text] [Related]
3. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit.
Rohracher A; Höfler J; Kalss G; Leitinger M; Kuchukhidze G; Deak I; Dobesberger J; Novak H; Pilz G; Zerbs A; Trinka E
Epilepsy Behav; 2015 Aug; 49():354-8. PubMed ID: 25962657
[TBL] [Abstract][Full Text] [Related]
4. Perampanel Treatment for Refractory Status Epilepticus in a Neurological Intensive Care Unit.
Ho CJ; Lin CH; Lu YT; Shih FY; Hsu CW; Tsai WC; Tsai MH
Neurocrit Care; 2019 Aug; 31(1):24-29. PubMed ID: 30891695
[TBL] [Abstract][Full Text] [Related]
5. Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain.
Strzelczyk A; Knake S; Kälviäinen R; Santamarina E; Toledo M; Willig S; Rohracher A; Trinka E; Rosenow F
Acta Neurol Scand; 2019 Apr; 139(4):369-376. PubMed ID: 30613951
[TBL] [Abstract][Full Text] [Related]
6. Use of perampanel oral suspension for the treatment of refractory and super-refractory status epilepticus.
Bruschi G; Pellegrino L; Bisogno AL; Ferreri F; Kassabian B; Seppi D; Favaretto S; Corbetta M; Dainese F
Epilepsy Behav; 2024 Jul; 156():109826. PubMed ID: 38761446
[TBL] [Abstract][Full Text] [Related]
7. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit: A single-center audit of 30 patients.
Rohracher A; Kalss G; Neuray C; Höfler J; Dobesberger J; Kuchukhidze G; Kreidenhuber R; Florea C; Thomschewski A; Novak HF; Pilz G; Leitinger M; Trinka E
Epilepsia; 2018 Oct; 59 Suppl 2():234-242. PubMed ID: 30043411
[TBL] [Abstract][Full Text] [Related]
8. Perampanel in achieving status epilepticus cessation: A systematic review.
Perez DQ; Espiritu AI; Jamora RDG
Epilepsy Behav; 2022 Mar; 128():108583. PubMed ID: 35151187
[TBL] [Abstract][Full Text] [Related]
9. Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study.
Hottinger A; Sutter R; Marsch S; Rüegg S
CNS Drugs; 2012 Sep; 26(9):761-72. PubMed ID: 22823481
[TBL] [Abstract][Full Text] [Related]
10. Vagus nerve stimulation in refractory and super-refractory status epilepticus - A systematic review.
Dibué-Adjei M; Brigo F; Yamamoto T; Vonck K; Trinka E
Brain Stimul; 2019; 12(5):1101-1110. PubMed ID: 31126871
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of ketamine in the treatment of refractory and super-refractory status epilepticus in children].
Wu J; Wang Q; Qian SY; Gao HM; Liu J; Deng J; Zeng JS
Zhonghua Er Ke Za Zhi; 2020 Apr; 58(4):295-300. PubMed ID: 32234136
[No Abstract] [Full Text] [Related]
13. Isoflurane in (Super-) Refractory Status Epilepticus: A Multicenter Evaluation.
Stetefeld HR; Schaal A; Scheibe F; Nichtweiß J; Lehmann F; Müller M; Gerner ST; Huttner HB; Luger S; Fuhrer H; Bösel J; Schönenberger S; Dimitriadis K; Neumann B; Fuchs K; Fink GR; Malter MP;
Neurocrit Care; 2021 Dec; 35(3):631-639. PubMed ID: 34286464
[TBL] [Abstract][Full Text] [Related]
14. Pediatric refractory and super-refractory status epilepticus.
Vasquez A; Farias-Moeller R; Tatum W
Seizure; 2019 May; 68():62-71. PubMed ID: 29941225
[TBL] [Abstract][Full Text] [Related]
15. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
[TBL] [Abstract][Full Text] [Related]
16. Perampanel in the treatment of status epilepticus: A systematic review of the literature.
Brigo F; Lattanzi S; Rohracher A; Russo E; Meletti S; Grillo E; Trinka E
Epilepsy Behav; 2018 Sep; 86():179-186. PubMed ID: 30076046
[TBL] [Abstract][Full Text] [Related]
17. Ketamine in the treatment of refractory and super-refractory status epilepticus: Experience from two centres.
García-Ruiz M; Rodríguez PM; Palliotti L; Lastras C; Romeral-Jiménez M; Morales IG; Rey CP; Rodrigo-Gisbert M; Campos-Fernández D; Santamarina E; Carbonell BP
Seizure; 2024 Apr; 117():13-19. PubMed ID: 38301485
[TBL] [Abstract][Full Text] [Related]
18. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study.
Delaj L; Novy J; Ryvlin P; Marchi NA; Rossetti AO
Acta Neurol Scand; 2017 Jan; 135(1):92-99. PubMed ID: 27080243
[TBL] [Abstract][Full Text] [Related]
19. (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.
Höfler J; Rohracher A; Kalss G; Zimmermann G; Dobesberger J; Pilz G; Leitinger M; Kuchukhidze G; Butz K; Taylor A; Novak H; Trinka E
CNS Drugs; 2016 Sep; 30(9):869-76. PubMed ID: 27465262
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of perampanel oral loading in postanoxic super-refractory status epilepticus: A pilot study.
Beretta S; Padovano G; Stabile A; Coppo A; Bogliun G; Avalli L; Ferrarese C
Epilepsia; 2018 Oct; 59 Suppl 2():243-248. PubMed ID: 30159874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
